Controlled Ovarian Stimulation Initiated at Different Phases of the Menstrual Cycle for Fertility Preservation in Oncological Patients: a Retrospective Study

被引:1
|
作者
Baig, A. Santolaria [1 ]
Camunas, N. Garcia [1 ]
Sanchez, P. Polo [1 ]
Nadal, J. Subira [1 ,2 ]
Fabuel, S. Monzo [1 ]
Rubio Rubio, J. M. [1 ]
机构
[1] Univ & Polytech La Fe Hosp, Human Reprod Unit, Valencia, Spain
[2] IVIRMA, Valencia, Spain
关键词
Random start; Controlled ovarian stimulation; Fertility preservation; Oncological patients; FORT; FOI; RANDOM-START; BREAST-CANCER; OOCYTE CRYOPRESERVATION; LETROZOLE; PROTOCOLS; WOMEN;
D O I
10.1007/s43032-023-01175-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The purpose of this study is to compare conventional start in early follicular phase (EFP) with late follicular phase (LFP) and luteal phase (LP) in controlled ovarian stimulation (COS) for fertility preservation (FP) to assess differences in clinical outcomes. Retrospective study of the first cycles of COS for FP in oncological patients between 2012 and 2020 in a tertiary hospital. Two-hundred forty-eight cycles were classified into 3 groups: 176 cycles in EFP, 8 cycles in LFP, and 52 cycles in LP. Comparing LFP to EFP, there were no differences in number of oocytes (10.0 [6.3-16.0] vs 12.0 [8.0-18.0]; p = 0.253) or number of metaphase II (MII) obtained (7.0 [2.3-13.3] vs 9.0 [6.0-13.0]; p = 0.229). Total number of days needed was higher in LFP (14.5 [12.5-16.0] vs 3.0 vs 10.0 [8.3-11.0 p = 0.000) but without significant differences in number of days of usage of gonadotropins (11.5 [8.3-12.8] vs 10.0 [8.3-11.0] p = 0.308). No differences were found between LP and EFP in number of oocytes (14.5 [9.0-20.0] p = 0.151) or MII (11.5 [7.0-16.0] p = 0.084). Number of days of gonadotropins (11.0 [10.0-12.0] p = 0.00) and total dosing (3000.0 [2475.0-3600.0] p = 0.013) were significantly higher in LP. FORT and FOI were similar in all groups. COS with a random start in fertility preservation has similar outcomes to EFP start. Therefore, we can initiate COS at any phase of the menstrual cycle with optimal results. However, LP may need more days of stimulation.
引用
收藏
页码:2547 / 2553
页数:7
相关论文
共 50 条
  • [41] A retrospective study evaluating the impact of scattering radiation from imaging procedures on oocyte quality during ovarian stimulation for fertility preservation in young breast cancer patients
    Margherita Condorelli
    Maëlle Sens
    Oranite Goldrat
    Anne Delbaere
    Judith Racapé
    Matteo Lambertini
    Isabelle Demeestere
    Breast Cancer Research and Treatment, 2022, 192 : 123 - 130
  • [42] Initiation of ovarian stimulation independent of the menstrual cycle: a case–control study
    Nana Kristin Buendgen
    Askan Schultze-Mosgau
    Tim Cordes
    Klaus Diedrich
    Georg Griesinger
    Archives of Gynecology and Obstetrics, 2013, 288 : 901 - 904
  • [43] Fertility preservation in patients with gynaecologic malignancy: Response to ovarian stimulation and long-term outcomes
    Tsonis, Orestis
    Kopeika, Julia
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2023, 290 : 93 - 100
  • [44] Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen
    Oktay, K
    Buyuk, E
    Davis, O
    Yermakova, I
    Veeck, L
    Rosenwaks, Z
    HUMAN REPRODUCTION, 2003, 18 (01) : 90 - 95
  • [45] Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis
    Bonardi, Benedetta
    Massarotti, Claudia
    Bruzzone, Marco
    Goldrat, Oranite
    Mangili, Giorgia
    Anserini, Paola
    Spinaci, Stefano
    Arecco, Luca
    Del Mastro, Lucia
    Ceppi, Marcello
    Demeestere, Isabelle
    Lambertini, Matteo
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [46] Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation
    Pereira, Nigel
    Kelly, Amelia G.
    Stone, Logan D.
    Witzke, Justine D.
    Lekovich, Jovana P.
    Elias, Rony T.
    Schattman, Glenn L.
    Rosenwaks, Zev
    FERTILITY AND STERILITY, 2017, 108 (03) : 532 - 538
  • [47] Timing Clinic Visits to Phases of the Menstrual Cycle by Using a Fertility Monitor: The BioCycle Study
    Howards, Penelope P.
    Schisterman, Enrique F.
    Wactawski-Wende, Jean
    Reschke, Jennifer E.
    Frazer, Andrea A.
    Hovey, Kathleen M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (01) : 105 - 112
  • [48] Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection
    Qin, Ningxin
    Chen, Qiuju
    Hong, Qingqing
    Cai, Renfei
    Gao, Hongyuan
    Wang, Yun
    Sun, Lihua
    Zhang, Shaozhen
    Guo, Haiyan
    Fu, Yonglun
    Ai, Ai
    Tian, Hui
    Lyu, Qifeng
    Daya, Salim
    Kuang, Yanping
    FERTILITY AND STERILITY, 2016, 106 (02) : 334 - U143
  • [49] Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report
    Cai, H.
    Shen, H.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2016, 49 (06) : 1 - 4
  • [50] Fertility preservation for women with ovarian endometriosis: results from a retrospective cohort study
    Elizur, Shai E.
    Aizer, Adva
    Yonish, Michal
    Shavit, Tal
    Orvieto, Raoul
    Mashiach, Roy
    Cohen, Shlomo B.
    Berkowitz, Elad
    REPRODUCTIVE BIOMEDICINE ONLINE, 2023, 46 (02) : 332 - 337